{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:50:15Z","timestamp":1779220215089,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","award":["H26-Nanchi-071"],"award-info":[{"award-number":["H26-Nanchi-071"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["15ek0109124"],"award-info":[{"award-number":["15ek0109124"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jiac.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T01:46:02Z","timestamp":1450403162000},"page":"268-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein\u2013Barr virus disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Yoshinori","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2015.11.002_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2015.11.002_bib2","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2015.11.002_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2015.11.002_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jiac.2015.11.002_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jiac.2015.11.002_bib6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/587671","article-title":"Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation","volume":"46","author":"Gotoh","year":"2008","journal-title":"Clin Infec Dis"},{"key":"10.1016\/j.jiac.2015.11.002_bib7","series-title":"Collaborative study to evaluate the proposed 1st WHO international standard for Epstein-Barr virus (EBV) for nucleic acid amplification technology (NAT)-based assays","author":"Fryer","year":"2011"},{"key":"10.1016\/j.jiac.2015.11.002_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay","volume":"37","author":"Kimura","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2015.11.002_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","article-title":"Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease","volume":"18","author":"Kimura","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jiac.2015.11.002_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1586\/eci.12.111","article-title":"Determining EBV load: current best practice and future requirements","volume":"9","author":"Ruf","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jiac.2015.11.002_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-6143.2008.02514.x","article-title":"Interlaboratory comparison of epstein-barr virus viral load assays","volume":"9","author":"Preiksaitis","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jiac.2015.11.002_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2015.11.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/317653","article-title":"Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection","volume":"183","author":"Ohga","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2015.11.002_bib14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:54:42Z","timestamp":1761159282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X15002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1341321X15002597"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2015.11.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein\u2013Barr virus disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}